Status:
WITHDRAWN
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
Université de Montréal
Conditions:
Epilepsy
Focal Cortical Dysplasia
Eligibility:
All Genders
Phase:
NA
Brief Summary
Refractory epilepsy, meaning epilepsy that no longer responds to medication, is a common neurosurgical indication in children. In such cases, surgery is the treatment of choice. Complete resection of ...
Detailed Description
Rationale: Refractory epilepsy, meaning epilepsy that no longer responds to medication, is a common neurosurgical indication in children. Focal cortical dysplasia (FCD) is the most common cause. Tuber...
Eligibility Criteria
Inclusion
- Participants with epilepsy who candidates for surgical treatment as established by a multidisciplinary committee specialized in epilepsy.
- Participants undergoing resective surgery for epilepsy of dysplastic (examples: focal cortical dysplasia, tuberous sclerosis, hemimegalencephaly, polymicrogyria) or non-dysplastic etiology (examples: developmental tumors, gliosis, stroke, Rasmussen encephalitis, Sturge-Weber syndrome).
Exclusion
- Lesion of interest located in a difficult to access region, such as paralimbic structures, insula, depth-of-sulci or inter-hemispheric.
Key Trial Info
Start Date :
July 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04344626
Start Date
July 16 2018
End Date
March 1 2023
Last Update
October 10 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Mattel Children's Hospital
Los Angeles, California, United States, 90095
2
Sainte-Justine University Hospital
Montreal, Quebec, Canada, H3T1C5